Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Tianli Pharmaceutical is a China-based biochemical and pharmaceutical manufacturer focused on commercial production of vitamin C, vitamin C derivatives, sugar alcohols, glucose, trehalose, and related corn deep-processing products. The company presents itself as a high-tech, Sino-foreign joint venture and states that it operates a fully integrated production chain from corn starch through sorbitol, mannitol, trehalose, and vitamin C. Its products are sold into pharmaceutical, food, nutrition, personal care, and industrial markets rather than through a classic innovative drug-development pipeline. Tianli appears to be part of the broader Shandong Lianmeng Chemical Group ecosystem and markets large-scale manufacturing capabilities, quality control, and global export supply. Based on available public information, it is best characterized as a commercial specialty biochemical/pharma ingredient producer rather than a clinical-stage biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Tianli Pharmaceutical.